Stromatis Pharma is a company that specializes in developing antibodies for unique and unmet targets, with a focus on reversing stromal stellate cells through a secreted frizzle-related protein 2 (sFRP2) antagonist. The company has a portfolio of five IP protected antibodies and a platform technology that allows for the generation of new proprietary antibodies.

Disease Domain	Count

Neoplasms	7
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Monoclonal antibody	4
Antibody drug conjugate (ADC)	2
CAR-T	1

Top 5 Target	Count

CEACAM5 x CEACAM6 x Top I	2
CEACAM5 x CEACAM6	1
CEACAM5(Carcinoembryonic antigen related cell adhesion molecule 5)	1
nectin-4	1
ROR1(Inactive tyrosine-protein kinase transmembrane receptor ROR1)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 11 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Current Projects

Drug(Targets)	Indications	Global Highest Phase

CT109-ADC ( CEACAM5 x CEACAM6 x Top I )	Neoplasms More	Preclinical
CT37(Stromatis Pharma) ( CEACAM5 )	Neoplasms More	Preclinical
ST-442(Stromatis Pharma) ( SFRP2 )	Neoplasms More	Preclinical
CT109-SN-38 ( CEACAM5 x CEACAM6 x Top I )	Pancreatic Cancer More	Preclinical
CT109-CAR-T(Stromatis Pharma) ( CEACAM5 x CEACAM6 )	Neoplasms More	Preclinical

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis